首页 > 最新文献

Health Services Research最新文献

英文 中文
Exploring the Early Effects of State Consumer Protection Policies on Medical Debt in Collections 探索国家消费者保护政策对医疗债务催收的早期影响。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-17 DOI: 10.1111/1475-6773.70068
Fredric Blavin, Breno Braga, Michael Karpman, Dulce Gonzalez, Maanasa Kona

Objective

To test if state consumer protection policies reduce the share of consumers with medical debt in collections on their credit reports.

Study Setting and Design

This study uses a quasi-experimental research design to estimate the impact of consumer protection laws implemented between 2020 and 2022 in Illinois, Maryland, New Mexico, and Oregon on the share of consumers with medical debt in collections. These laws primarily aim to protect consumers against medical debt by expanding access to hospital financial assistance. We use a synthetic control approach to estimate changes in medical debt following the implementation of policies in treatment states relative to changes in select control states. We also assess the effects of earlier policies implemented between 2013 and 2019 in Washington, Utah, and North Carolina.

Data Sources and Analytic Sample

This analysis relies on two extracts of credit bureau data from one of the country's three main credit bureau agencies. The first extract consists of random samples from June 2017 to June 2024 of approximately 125,000 consumers in each treatment state and 500,000 residents from the pool of 14 selected comparison states in each year. The second extract is based on a 2%–4% random sample of consumers in each year from 2011 to 2022.

Principal Findings

We did not observe a statistically significant reduction in medical debt associated with policies implemented in these states within the study timeframe. In most states in our primary analysis, point estimates of the treatment effects are near zero, and in nearly all state-years, we can only rule out declines in medical debt larger than 1–3 percentage points following policy implementation.

Conclusions

Though we did not detect statistically significant effects of recent consumer protection policies on medical debt in collections, additional research is needed on whether these policies benefited consumers in ways that are not measured in this analysis and whether states that continue to move forward with similar laws can improve their effectiveness by extending consumer protections to a wider group of patients and providers and addressing implementation and enforcement challenges.

目的:检验国家消费者保护政策是否减少了消费者在信用报告中医疗债务的收集份额。研究设置和设计:本研究采用准实验研究设计来估计2020年至2022年在伊利诺伊州、马里兰州、新墨西哥州和俄勒冈州实施的消费者保护法对医疗债务催收消费者比例的影响。这些法律的主要目的是通过扩大获得医院财政援助的机会来保护消费者免受医疗债务的影响。我们使用一种综合控制方法来估计在治疗州实施政策后医疗债务的变化相对于选择控制州的变化。我们还评估了2013年至2019年期间在华盛顿州、犹他州和北卡罗来纳州实施的早期政策的影响。数据来源和分析样本:本分析依赖于来自该国三家主要征信机构之一的征信机构数据的两个摘录。第一个提取由2017年6月至2024年6月的随机样本组成,每个处理州约有12.5万名消费者,每年从14个选定的比较州中抽取50万名居民。第二个提取是基于从2011年到2022年每年2%-4%的随机消费者样本。主要发现:在研究时间框架内,我们没有观察到与这些州实施的政策相关的医疗债务的统计学显著减少。在我们的初步分析中,对大多数州的治疗效果的点估计接近于零,而且在几乎所有州的年份中,我们只能排除在政策实施后医疗债务下降幅度大于1-3个百分点的可能性。结论:虽然我们没有发现最近的消费者保护政策对医疗债务收集的统计显着影响,但需要进一步研究这些政策是否以本分析中未测量的方式使消费者受益,以及继续推进类似法律的州是否可以通过将消费者保护扩展到更广泛的患者和提供者群体并解决实施和执行挑战来提高其有效性。
{"title":"Exploring the Early Effects of State Consumer Protection Policies on Medical Debt in Collections","authors":"Fredric Blavin,&nbsp;Breno Braga,&nbsp;Michael Karpman,&nbsp;Dulce Gonzalez,&nbsp;Maanasa Kona","doi":"10.1111/1475-6773.70068","DOIUrl":"10.1111/1475-6773.70068","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To test if state consumer protection policies reduce the share of consumers with medical debt in collections on their credit reports.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Setting and Design</h3>\u0000 \u0000 <p>This study uses a quasi-experimental research design to estimate the impact of consumer protection laws implemented between 2020 and 2022 in Illinois, Maryland, New Mexico, and Oregon on the share of consumers with medical debt in collections. These laws primarily aim to protect consumers against medical debt by expanding access to hospital financial assistance. We use a synthetic control approach to estimate changes in medical debt following the implementation of policies in treatment states relative to changes in select control states. We also assess the effects of earlier policies implemented between 2013 and 2019 in Washington, Utah, and North Carolina.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 \u0000 <p>This analysis relies on two extracts of credit bureau data from one of the country's three main credit bureau agencies. The first extract consists of random samples from June 2017 to June 2024 of approximately 125,000 consumers in each treatment state and 500,000 residents from the pool of 14 selected comparison states in each year. The second extract is based on a 2%–4% random sample of consumers in each year from 2011 to 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>We did not observe a statistically significant reduction in medical debt associated with policies implemented in these states within the study timeframe. In most states in our primary analysis, point estimates of the treatment effects are near zero, and in nearly all state-years, we can only rule out declines in medical debt larger than 1–3 percentage points following policy implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Though we did not detect statistically significant effects of recent consumer protection policies on medical debt in collections, additional research is needed on whether these policies benefited consumers in ways that are not measured in this analysis and whether states that continue to move forward with similar laws can improve their effectiveness by extending consumer protections to a wider group of patients and providers and addressing implementation and enforcement challenges.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nursing Homes as Insurers? The Effect of Provider-Led Institutional Special Needs Plans 养老院是保险公司吗?提供者主导的机构特殊需要计划的效果。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-09 DOI: 10.1111/1475-6773.70067
Amanda C. Chen, J. Michael McWilliams, Mary Beth Landrum, David C. Grabowski

Objective

To estimate the effect of starting a provider-led Institutional Special Needs Plan (I-SNP) arrangement on facility-level enrollment, utilization, and quality.

Study Setting and Design

I-SNPs are a type of Medicare Advantage (MA) plan that allows insurers to differentiate their benefits exclusively for long-term residents in nursing homes. Since I-SNPs first became available in 2006, there has been growth in provider-led I-SNPs where nursing homes are financially integrated or partnered with an insurer to operate a plan for their own residents. We used a difference-in-differences design to estimate the effect of starting a provider-led I-SNP arrangement on several facility-level outcomes, including the share of a facility's long-stay residents who were enrolled in an I-SNP, hospitalizations, medication use, pressure ulcers, physical restraints, falls, and mortality.

Data Sources and Analytic Sample

We used Medicare claims and nursing home resident assessments (2004–2021) to identify Medicare long-stay nursing home residents.

Principal Findings

The start of a provider-led I-SNP arrangement led to a 17.0 percentage point (pp) increase (standard error [SE]: 0.006) in I-SNP enrollment among facility residents within 4 years relative to control nursing homes. We also estimate that the start of a provider-led I-SNP arrangement significantly decreased hospitalizations (−1.0 pp, SE: 0.002), increased the use of antipsychotic (0.4 pp, SE: 0.002) and hypnotic drugs (0.3 pp, SE: 0.001), and reporting of pressure ulcers (0.4 pp, SE: 0.002).

Conclusions

Provider-led I-SNPs allow nursing homes to bear financial risk for their residents. These results suggest that this form of risk bearing may successfully reduce utilization (e.g., hospitalizations), but with unclear implications for quality as increased use of sedating drugs and rates of pressure ulcers could either reflect poorer care or retention of sicker patients due to lower hospitalization rates.

目的:评估启动提供者主导的机构特殊需要计划(I-SNP)安排对设施级招生、利用和质量的影响。研究设置和设计:i - snp是一种医疗保险优势(MA)计划,允许保险公司为养老院的长期居民区分他们的福利。自从2006年i - snp首次出现以来,由提供者主导的i - snp出现了增长,这些养老院在财务上整合或与保险公司合作,为自己的居民运营一项计划。我们使用差异中之差设计来估计启动提供者主导的I-SNP安排对几个设施级结果的影响,包括设施长期住院居民参与I-SNP的比例、住院情况、药物使用、压疮、身体约束、跌倒和死亡率。数据来源和分析样本:我们使用医疗保险索赔和养老院居民评估(2004-2021)来确定医疗保险长期居住的养老院居民。主要发现:与对照疗养院相比,由提供者主导的I-SNP安排的开始导致4年内设施居民中I-SNP入学率增加17.0个百分点(标准误差[SE]: 0.006)。我们还估计,提供者主导的I-SNP安排的开始显著降低了住院率(-1.0 pp, SE: 0.002),增加了抗精神病药物(0.4 pp, SE: 0.002)和催眠药物(0.3 pp, SE: 0.001)的使用,并报告了压疮(0.4 pp, SE: 0.002)。结论:提供者主导的i - snp允许养老院为其居民承担财务风险。这些结果表明,这种形式的风险承担可能会成功地减少使用率(例如住院率),但对质量的影响尚不清楚,因为镇静药物使用的增加和压疮的发生率可能反映出较差的护理或由于住院率较低而导致病情较重的患者滞留。
{"title":"Nursing Homes as Insurers? The Effect of Provider-Led Institutional Special Needs Plans","authors":"Amanda C. Chen,&nbsp;J. Michael McWilliams,&nbsp;Mary Beth Landrum,&nbsp;David C. Grabowski","doi":"10.1111/1475-6773.70067","DOIUrl":"10.1111/1475-6773.70067","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To estimate the effect of starting a provider-led Institutional Special Needs Plan (I-SNP) arrangement on facility-level enrollment, utilization, and quality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Setting and Design</h3>\u0000 \u0000 <p>I-SNPs are a type of Medicare Advantage (MA) plan that allows insurers to differentiate their benefits exclusively for long-term residents in nursing homes. Since I-SNPs first became available in 2006, there has been growth in provider-led I-SNPs where nursing homes are financially integrated or partnered with an insurer to operate a plan for their own residents. We used a difference-in-differences design to estimate the effect of starting a provider-led I-SNP arrangement on several facility-level outcomes, including the share of a facility's long-stay residents who were enrolled in an I-SNP, hospitalizations, medication use, pressure ulcers, physical restraints, falls, and mortality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 \u0000 <p>We used Medicare claims and nursing home resident assessments (2004–2021) to identify Medicare long-stay nursing home residents.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>The start of a provider-led I-SNP arrangement led to a 17.0 percentage point (pp) increase (standard error [SE]: 0.006) in I-SNP enrollment among facility residents within 4 years relative to control nursing homes. We also estimate that the start of a provider-led I-SNP arrangement significantly decreased hospitalizations (−1.0 pp, SE: 0.002), increased the use of antipsychotic (0.4 pp, SE: 0.002) and hypnotic drugs (0.3 pp, SE: 0.001), and reporting of pressure ulcers (0.4 pp, SE: 0.002).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Provider-led I-SNPs allow nursing homes to bear financial risk for their residents. These results suggest that this form of risk bearing may successfully reduce utilization (e.g., hospitalizations), but with unclear implications for quality as increased use of sedating drugs and rates of pressure ulcers could either reflect poorer care or retention of sicker patients due to lower hospitalization rates.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence, Persistence, and Steady-State Prevalence in Coding Intensity for Health Plan Payment 健康计划支付编码强度的发生率、持久性和稳态患病率。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-08 DOI: 10.1111/1475-6773.70065
Thomas G. McGuire, Oana M. Enache, Michael Chernew, J. Michael McWilliams, Tram Nham, Sherri Rose

Objective

To define measures of Medicare diagnosis coding intensity that capture the dynamics of changes in coding practices.

Study Setting and Design

Retrospective analysis of coding for risk adjustment using observational claims data from Medicare beneficiaries.

Data Sources

Enrollment and claims data from 2017 and 2018 of a random 20% sample of Medicare beneficiaries were subset to those assigned to an Accountable Care Organization in 2018.

Principal Findings

We decompose the prevalence of a diagnosis code into incidence (proportion of beneficiaries that newly have the code) and persistence (proportion of beneficiaries who previously had the code and continue to do so). Together these define steady-state prevalence, the hypothetical long-run prevalence implied by no changes in current rates of incidence and persistence of coding. Steady-state prevalence can help explain why observed prevalence tends to grow over time without continued behavioral change. For example, our measures suggest that the prevalence of the Specified Heart Arrhythmias diagnosis would continue to rise from 18.7% in 2018 to 28.0% without changes in coding practices.

Conclusions

Researchers and policymakers can better understand why changes in coding practices can take years to be fully reflected in data and monitor coding behavior by using our proposed measures.

目的:定义医疗保险诊断编码强度的测量方法,以捕捉编码实践变化的动态。研究设置和设计:使用来自医疗保险受益人的观察性索赔数据对风险调整编码进行回顾性分析。数据来源:2017年和2018年随机抽取20%的医疗保险受益人样本的登记和索赔数据是2018年分配给负责任医疗组织的数据的子集。主要发现:我们将诊断代码的流行度分解为发生率(新拥有代码的受益人比例)和持久性(以前拥有代码并继续使用代码的受益人比例)。这些共同定义了稳态患病率,即假设的长期患病率,即当前发病率和编码持久性不变所隐含的患病率。稳态患病率可以帮助解释为什么观察到的患病率随着时间的推移而没有持续的行为改变。例如,我们的测量结果表明,在编码实践没有改变的情况下,特定心律失常诊断的患病率将继续从2018年的18.7%上升到28.0%。结论:研究人员和政策制定者可以更好地理解为什么编码实践的变化需要数年才能完全反映在数据中,并通过使用我们提出的措施来监测编码行为。
{"title":"Incidence, Persistence, and Steady-State Prevalence in Coding Intensity for Health Plan Payment","authors":"Thomas G. McGuire,&nbsp;Oana M. Enache,&nbsp;Michael Chernew,&nbsp;J. Michael McWilliams,&nbsp;Tram Nham,&nbsp;Sherri Rose","doi":"10.1111/1475-6773.70065","DOIUrl":"10.1111/1475-6773.70065","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To define measures of Medicare diagnosis coding intensity that capture the dynamics of changes in coding practices.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>Retrospective analysis of coding for risk adjustment using observational claims data from Medicare beneficiaries.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources</h3>\u0000 <p>Enrollment and claims data from 2017 and 2018 of a random 20% sample of Medicare beneficiaries were subset to those assigned to an Accountable Care Organization in 2018.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>We decompose the prevalence of a diagnosis code into incidence (proportion of beneficiaries that newly have the code) and persistence (proportion of beneficiaries who previously had the code and continue to do so). Together these define steady-state prevalence, the hypothetical long-run prevalence implied by no changes in current rates of incidence and persistence of coding. Steady-state prevalence can help explain why observed prevalence tends to grow over time without continued behavioral change. For example, our measures suggest that the prevalence of the Specified Heart Arrhythmias diagnosis would continue to rise from 18.7% in 2018 to 28.0% without changes in coding practices.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusions</h3>\u0000 <p>Researchers and policymakers can better understand why changes in coding practices can take years to be fully reflected in data and monitor coding behavior by using our proposed measures.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Care of Patients With Chronic Conditions and Clinician Participation in Accountable Care Organizations 慢性病患者的护理和临床医生在负责任的护理组织中的参与。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-05 DOI: 10.1111/1475-6773.70064
Alexander O. Everhart, Peter F. Lyu, Jason M. Hockenberry, Karen E. Joynt Maddox, Kenton J. Johnston

Objective

To compare chronic condition specialists to primary care providers (PCPs) on rates of serving as the usual provider of care (UPC, defined as providing the most visits) versus being accountable under “PCP-first” assignment used in accountable care organization (ACO) programs, and to compare risk-based ACO participation.

Study Setting and Design

We conducted a retrospective cohort study of PCP versus chronic condition specialty clinicians on their rates of serving as UPC for patients with complex chronic conditions, patient assignment under a “PCP-first” assignment mechanism, and participation in risk-based ACOs. We then estimated linear probability models predicting clinician participation in risk-based ACOs as a function of their rates of serving as the UPC.

Data Sources and Analytic Sample

We used 100% traditional fee-for-service Medicare (TM) clinician data and beneficiary claims from 2017 to 2022.

Principal Findings

The study included 2,065,755 and 254,918 clinician-years for PCPs and chronic condition specialists (cardiology, endocrinology, nephrology, pulmonology), respectively. Specialists more often served as the UPC than they were accountable under PCP-first assignment algorithms (7.9% UPC vs. 3.3% PCP-first assignment); the opposite was true of PCPs (19.2% vs. 29.8%). Specialists in the top quintile for serving as UPC were 19.0% less likely (4.4 percentage point [pp] absolute difference, 95% CI, 3.7–5.1 pp) to participate in risk-based ACOs than specialists in the bottom quintile. PCPs in the top UPC quintile were 18.7% more likely (3.8 pp. absolute difference, 95% CI, 3.6–4.1 pp) to participate in risk-based ACOs than PCPs in the bottom quintile.

Conclusions

Existing assignment mechanisms in Medicare ACOs may undervalue specialists' care for patients with chronic conditions. More efforts are needed to engage specialists in accountable care.

目的:比较慢性病专家和初级保健提供者(pcp)作为常规护理提供者(UPC,定义为提供最多的访问量)的比率与在负责任的护理组织(ACO)计划中使用的“pcp优先”分配下负责的比率,并比较基于风险的ACO参与。研究设置和设计:我们对PCP和慢性病专科临床医生进行了一项回顾性队列研究,比较了他们为复杂慢性病患者担任UPC的比率、“PCP优先”分配机制下的患者分配以及参与基于风险的ACOs。然后,我们估计了线性概率模型,预测临床医生参与基于风险的ACOs,作为其作为UPC的比率的函数。数据来源和分析样本:我们使用2017年至2022年100%的传统按服务收费的医疗保险(TM)临床医生数据和受益人索赔。主要发现:该研究包括pcp和慢性病专家(心脏病学、内分泌学、肾脏病学、肺病学)分别2,065,755和254,918临床年。专家更多地担任UPC,而不是在pcp优先分配算法下负责(7.9%的UPC vs. 3.3%的pcp优先分配);pcp则相反(19.2% vs 29.8%)。作为UPC的前五分之一的专家参与基于风险的ACOs的可能性比后五分之一的专家低19.0%(4.4个百分点[pp]绝对差异,95% CI, 3.7-5.1 pp)。在UPC前五分之一的pcp有18.7%的可能性(3.8个)。绝对差异,95% CI, 3.6-4.1 pp)参加基于风险的ACOs的比例高于最低五分之一的pcp。结论:现有的医疗保险ACOs分配机制可能低估了专家对慢性病患者的护理。需要作出更多努力,让专家参与负责任的护理。
{"title":"Care of Patients With Chronic Conditions and Clinician Participation in Accountable Care Organizations","authors":"Alexander O. Everhart,&nbsp;Peter F. Lyu,&nbsp;Jason M. Hockenberry,&nbsp;Karen E. Joynt Maddox,&nbsp;Kenton J. Johnston","doi":"10.1111/1475-6773.70064","DOIUrl":"10.1111/1475-6773.70064","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To compare chronic condition specialists to primary care providers (PCPs) on rates of serving as the usual provider of care (UPC, defined as providing the most visits) versus being accountable under “PCP-first” assignment used in accountable care organization (ACO) programs, and to compare risk-based ACO participation.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>We conducted a retrospective cohort study of PCP versus chronic condition specialty clinicians on their rates of serving as UPC for patients with complex chronic conditions, patient assignment under a “PCP-first” assignment mechanism, and participation in risk-based ACOs. We then estimated linear probability models predicting clinician participation in risk-based ACOs as a function of their rates of serving as the UPC.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 <p>We used 100% traditional fee-for-service Medicare (TM) clinician data and beneficiary claims from 2017 to 2022.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>The study included 2,065,755 and 254,918 clinician-years for PCPs and chronic condition specialists (cardiology, endocrinology, nephrology, pulmonology), respectively. Specialists more often served as the UPC than they were accountable under PCP-first assignment algorithms (7.9% UPC vs. 3.3% PCP-first assignment); the opposite was true of PCPs (19.2% vs. 29.8%). Specialists in the top quintile for serving as UPC were 19.0% <i>less</i> likely (4.4 percentage point [pp] absolute difference, 95% CI, 3.7–5.1 pp) to participate in risk-based ACOs than specialists in the bottom quintile. PCPs in the top UPC quintile were 18.7% <i>more</i> likely (3.8 pp. absolute difference, 95% CI, 3.6–4.1 pp) to participate in risk-based ACOs than PCPs in the bottom quintile.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusions</h3>\u0000 <p>Existing assignment mechanisms in Medicare ACOs may undervalue specialists' care for patients with chronic conditions. More efforts are needed to engage specialists in accountable care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adapting the American Community Survey for the Affordable Care Act 为《平价医疗法案》调整美国社区调查。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-04 DOI: 10.1111/1475-6773.70066
Joanne Pascale, Angela R. Fertig

Objective

To measure the accuracy of questions on health insurance premiums and subsidies added to the American Community Survey (ACS) and their utility in categorizing coverage type following the Affordable Care Act (ACA).

Study Setting and Design

A reverse record check study where households in Minnesota with individuals enrolled in five different types of coverage—employer-sponsored insurance (ESI), non-group (outside the marketplace), marketplace, Medicaid and MinnesotaCare (a public plan requiring premium contributions from the enrollee)—were administered a telephone survey that included the ACS health insurance module appended with experimental questions on premiums and subsidies.

Data Sources and Analytic Sample

Enrollment records from a private insurer were used as the sample for primary survey data collection in the spring of 2015 using the ACS health insurance module. Survey data were matched back to enrollment records, which indicated coverage status at the time of the survey. The analytic sample includes matched data on about 600 individuals.

Principal Findings

In total, 100%, 95.3%, and 86.9% of marketplace, non-group, and ESI enrollees, respectively, were correctly reported to have a premium. 74.6% of Medicaid enrollees were correctly reported NOT to have a premium and 77.4% of MinnesotaCare enrollees were correctly reported to HAVE a premium. For the subsidy item, correct reports of no subsidy were 99.1%, 93.8%, and 80.9% for ESI, non-group, and unsubsidized marketplace enrollees, respectively. A total of 72.4% of subsidized marketplace enrollees were correctly reported to have a subsidy. Analysis also indicates that an algorithm leveraging these two new data points can be used to separate the overall “direct purchase” category into two sub-groups: subsidized marketplace and unsubsidized marketplace combined with individual non-group.

Conclusions

Results indicate high levels of reporting accuracy for questions about premiums and subsidies. Thus, this post-ACA module of the ACS is capable of rendering more detailed coverage types than previously possible.

目的:衡量美国社区调查(ACS)中增加的健康保险保费和补贴问题的准确性及其在《平价医疗法案》(ACA)实施后对覆盖类型进行分类的效用。研究设置和设计:一项反向记录检查研究,在明尼苏达州的家庭中,有个人参加了五种不同类型的保险——雇主赞助保险(ESI)、非团体保险(市场外)、市场保险、医疗补助计划和明尼苏达州医疗保险(一种要求参保者缴纳保费的公共计划)——进行了一次电话调查,其中包括ACS健康保险模块,附带关于保费和补贴的实验问题。数据来源和分析样本:使用ACS健康保险模块,以一家私营保险公司的登记记录为样本,于2015年春季进行初步调查数据收集。调查数据与登记记录相匹配,登记记录显示了调查时的覆盖状况。分析样本包括大约600个人的匹配数据。主要发现:总体而言,100%、95.3%和86.9%的市场参保者、非团体参保者和ESI参保者被正确地报告为拥有保费。74.6%的医疗补助计划参保人被正确地报告为没有保险费,77.4%的明尼苏达州医保参保人被正确地报告为有保险费。对于补贴项目,ESI、非团体和非补贴市场参保者的无补贴报告正确率分别为99.1%、93.8%和80.9%。总共有72.4%的有补贴的市场参保人被正确地报告有补贴。分析还表明,利用这两个新数据点的算法可以将整个“直接购买”类别分为两个子组:补贴市场和非补贴市场与个别非群体相结合。结论:结果表明保费和补贴问题的报告准确性很高。因此,ACS的后aca模块能够呈现比以前更详细的覆盖类型。
{"title":"Adapting the American Community Survey for the Affordable Care Act","authors":"Joanne Pascale,&nbsp;Angela R. Fertig","doi":"10.1111/1475-6773.70066","DOIUrl":"10.1111/1475-6773.70066","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To measure the accuracy of questions on health insurance premiums and subsidies added to the American Community Survey (ACS) and their utility in categorizing coverage type following the Affordable Care Act (ACA).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Setting and Design</h3>\u0000 \u0000 <p>A reverse record check study where households in Minnesota with individuals enrolled in five different types of coverage—employer-sponsored insurance (ESI), non-group (outside the marketplace), marketplace, Medicaid and MinnesotaCare (a public plan requiring premium contributions from the enrollee)—were administered a telephone survey that included the ACS health insurance module appended with experimental questions on premiums and subsidies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 \u0000 <p>Enrollment records from a private insurer were used as the sample for primary survey data collection in the spring of 2015 using the ACS health insurance module. Survey data were matched back to enrollment records, which indicated coverage status at the time of the survey. The analytic sample includes matched data on about 600 individuals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>In total, 100%, 95.3%, and 86.9% of marketplace, non-group, and ESI enrollees, respectively, were correctly reported to have a premium. 74.6% of Medicaid enrollees were correctly reported NOT to have a premium and 77.4% of MinnesotaCare enrollees were correctly reported to HAVE a premium. For the subsidy item, correct reports of no subsidy were 99.1%, 93.8%, and 80.9% for ESI, non-group, and unsubsidized marketplace enrollees, respectively. A total of 72.4% of subsidized marketplace enrollees were correctly reported to have a subsidy. Analysis also indicates that an algorithm leveraging these two new data points can be used to separate the overall “direct purchase” category into two sub-groups: subsidized marketplace and unsubsidized marketplace combined with individual non-group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Results indicate high levels of reporting accuracy for questions about premiums and subsidies. Thus, this post-ACA module of the ACS is capable of rendering more detailed coverage types than previously possible.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State Proposed Strategies to Expand Access to Medications for Opioid Use Disorder 国家提出的扩大获得阿片类药物使用障碍药物的战略。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-31 DOI: 10.1111/1475-6773.70061
Andrea Baron, Jennifer D. Hall, Jordan Byers, Stephan Lindner, Deborah J. Cohen

Objective

To identify state strategies to increase access to medications for opioid use disorder (MOUD) through Section 1115 Substance Use Disorder waivers.

Study Setting and Design

We conducted a qualitative analysis of 27 waiver applications that were implemented between 2015 and 2020. We identified barriers and proposed strategies for expanding MOUD access and utilization.

Data Sources and Analytic Sample

After excluding five states due to insufficient information, we analyzed 22 applications.

Principal Findings

We identified six barriers and eight corresponding strategies. Barriers included care delays, limited MOUD facilities, lack of care transition support, limited MOUD access in residential treatment, insufficient care coordination, and prescriber shortages. Commonly proposed strategies were requiring access to MOUD in residential treatment, which was stipulated by the Centers for Medicare & Medicaid Services, addressing prescriber shortages through education and technical assistance, campaigns to address stigma, and increased reimbursement. Other strategies included changes to prior authorization requirements, efforts to increase the number of facilities that offer MOUD, and changes to improve care transitions.

Conclusions

States proposed a variety of strategies to expand access to and use of MOUD. Future research could investigate how these approaches, implemented individually or in combination, are associated with outcome change and impact.

目的:通过第1115节物质使用障碍豁免,确定各州增加阿片类药物使用障碍(mod)药物可及性的策略。研究设置和设计:我们对2015年至2020年间实施的27项豁免申请进行了定性分析。我们确定了障碍并提出了扩大mod访问和利用的策略。数据来源和分析样本:在排除了信息不足的5个州后,我们分析了22个应用。主要发现:我们确定了6个障碍和8个相应的策略。障碍包括护理延误、护理设施有限、缺乏护理过渡支持、住院治疗中护理人员有限、护理协调不足和处方人员短缺。通常提出的策略是要求在住院治疗中使用mod,这是由医疗保险和医疗补助服务中心规定的,通过教育和技术援助解决处方人员短缺问题,开展运动来解决耻辱感,增加报销。其他策略包括改变事先授权要求,努力增加提供mod的设施数量,以及改变以改善护理过渡。结论:各国提出了各种战略,以扩大mod的获取和使用。未来的研究可以调查这些方法,单独实施或组合实施,如何与结果变化和影响相关联。
{"title":"State Proposed Strategies to Expand Access to Medications for Opioid Use Disorder","authors":"Andrea Baron,&nbsp;Jennifer D. Hall,&nbsp;Jordan Byers,&nbsp;Stephan Lindner,&nbsp;Deborah J. Cohen","doi":"10.1111/1475-6773.70061","DOIUrl":"10.1111/1475-6773.70061","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To identify state strategies to increase access to medications for opioid use disorder (MOUD) through Section 1115 Substance Use Disorder waivers.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>We conducted a qualitative analysis of 27 waiver applications that were implemented between 2015 and 2020. We identified barriers and proposed strategies for expanding MOUD access and utilization.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 <p>After excluding five states due to insufficient information, we analyzed 22 applications.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>We identified six barriers and eight corresponding strategies. Barriers included care delays, limited MOUD facilities, lack of care transition support, limited MOUD access in residential treatment, insufficient care coordination, and prescriber shortages. Commonly proposed strategies were requiring access to MOUD in residential treatment, which was stipulated by the Centers for Medicare &amp; Medicaid Services, addressing prescriber shortages through education and technical assistance, campaigns to address stigma, and increased reimbursement. Other strategies included changes to prior authorization requirements, efforts to increase the number of facilities that offer MOUD, and changes to improve care transitions.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusions</h3>\u0000 <p>States proposed a variety of strategies to expand access to and use of MOUD. Future research could investigate how these approaches, implemented individually or in combination, are associated with outcome change and impact.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of an Algorithm to Identify Prenatal Care in Administrative Data: Predictive Validity for Adverse Birth Outcomes 在行政数据中识别产前护理的算法的开发和验证:对不良出生结果的预测有效性。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-28 DOI: 10.1111/1475-6773.70063
Songyuan Deng, Greg Barabell, Kevin J. Bennett

Objective

To develop and validate a hierarchical algorithm for assigning prenatal care (PNC) encounters using claims data while ensuring continuity of care.

Study Setting and Design

We conducted a retrospective cohort study among South Carolina Medicaid beneficiaries. Using a six-step hierarchical algorithm—incorporating specialty designations, diagnostic/procedure codes, and adjustments for inpatient stays and supplemental visits—we assigned PNC encounters and identified predominant PNC providers. To assess predictive validity, we examined associations between predominant provider status and adverse birth outcomes (obtained from linked birth certificates and claims data) using logit-binomial generalized estimating equations with robust standard errors, and we compared models' performance using both model fit statistics and 10-fold cross-validation.

Data Sources and Analytic Sample

We used South Carolina Medicaid data on live-birth pregnancies from 2016 to 2021. We followed participants from conception until delivery.

Principal Findings

Initial screening identified 302 package/bundle payment claims, leading to the exclusion of 299 pregnancies (0.3%) from further analysis. The final analytic dataset contained 1,072,615 confirmed PNC encounters for 90,581 (97%) pregnancies. This study identified predominant providers for 87,573 pregnancies (98% of cases with at least two PNC encounters). The analysis of predictive validity revealed significant protective associations for two outcomes when comparing pregnancies with versus without predominant providers: preterm birth (adjusted RR: 0.68, 95% CI: 0.59–0.77) and low-birth-weight (adjusted RR: 0.68, 95% CI: 0.57–0.80).

Conclusions

This study developed and validated a claims-based algorithm to identify PNC utilization in South Carolina Medicaid data. Predictive validity tests revealed that predominant provider status was associated with reduced adverse birth outcomes, suggesting care continuity may improve perinatal health. Future research could apply this algorithm to examine causal relationships between predominant provider status and specific outcomes (e.g., preterm birth, low birth weight), while accounting for institutional and socioeconomic confounders. These findings offer a foundation for optimizing PNC delivery through continuity-focused interventions.

目的:开发和验证使用索赔数据分配产前护理(PNC)遭遇的分层算法,同时确保护理的连续性。研究背景和设计:我们在南卡罗来纳州医疗补助受益人中进行了一项回顾性队列研究。使用六步分级算法——包括专科指定、诊断/程序代码、住院和补充就诊调整——我们分配了PNC就诊并确定了主要的PNC提供者。为了评估预测有效性,我们使用具有稳健标准误差的logit-二项广义估计方程,检查了主要提供者地位与不良出生结果(从相关的出生证明和索赔数据中获得)之间的关联,并使用模型拟合统计和10倍交叉验证来比较模型的性能。数据来源和分析样本:我们使用了2016年至2021年南卡罗来纳州医疗补助计划的活产妊娠数据。我们跟踪参与者从受孕到分娩。主要发现:初步筛选确定了302个一揽子/捆绑付款索赔,导致299例妊娠(0.3%)被排除在进一步分析之外。最终的分析数据集包含90,581例(97%)妊娠中1,072,615例确诊的PNC遭遇。本研究确定了87,573例妊娠的主要提供者(98%的病例至少有两次PNC接触)。预测效度分析显示,当比较有和没有主要提供者的妊娠时,两种结局具有显著的保护性关联:早产(调整RR: 0.68, 95% CI: 0.59-0.77)和低出生体重(调整RR: 0.68, 95% CI: 0.57-0.80)。结论:本研究开发并验证了一种基于索赔的算法,以确定南卡罗来纳州医疗补助数据中PNC的使用情况。预测效度测试显示,主要提供者地位与减少不良分娩结果相关,表明护理连续性可能改善围产期健康。未来的研究可以应用该算法来检查主要提供者地位与特定结果(如早产、低出生体重)之间的因果关系,同时考虑制度和社会经济混杂因素。这些发现为通过以连续性为重点的干预措施优化PNC交付提供了基础。
{"title":"Development and Validation of an Algorithm to Identify Prenatal Care in Administrative Data: Predictive Validity for Adverse Birth Outcomes","authors":"Songyuan Deng,&nbsp;Greg Barabell,&nbsp;Kevin J. Bennett","doi":"10.1111/1475-6773.70063","DOIUrl":"10.1111/1475-6773.70063","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To develop and validate a hierarchical algorithm for assigning prenatal care (PNC) encounters using claims data while ensuring continuity of care.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>We conducted a retrospective cohort study among South Carolina Medicaid beneficiaries. Using a six-step hierarchical algorithm—incorporating specialty designations, diagnostic/procedure codes, and adjustments for inpatient stays and supplemental visits—we assigned PNC encounters and identified predominant PNC providers. To assess predictive validity, we examined associations between predominant provider status and adverse birth outcomes (obtained from linked birth certificates and claims data) using logit-binomial generalized estimating equations with robust standard errors, and we compared models' performance using both model fit statistics and 10-fold cross-validation.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 <p>We used South Carolina Medicaid data on live-birth pregnancies from 2016 to 2021. We followed participants from conception until delivery.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>Initial screening identified 302 package/bundle payment claims, leading to the exclusion of 299 pregnancies (0.3%) from further analysis. The final analytic dataset contained 1,072,615 confirmed PNC encounters for 90,581 (97%) pregnancies. This study identified predominant providers for 87,573 pregnancies (98% of cases with at least two PNC encounters). The analysis of predictive validity revealed significant protective associations for two outcomes when comparing pregnancies with versus without predominant providers: preterm birth (adjusted RR: 0.68, 95% CI: 0.59–0.77) and low-birth-weight (adjusted RR: 0.68, 95% CI: 0.57–0.80).</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusions</h3>\u0000 <p>This study developed and validated a claims-based algorithm to identify PNC utilization in South Carolina Medicaid data. Predictive validity tests revealed that predominant provider status was associated with reduced adverse birth outcomes, suggesting care continuity may improve perinatal health. Future research could apply this algorithm to examine causal relationships between predominant provider status and specific outcomes (e.g., preterm birth, low birth weight), while accounting for institutional and socioeconomic confounders. These findings offer a foundation for optimizing PNC delivery through continuity-focused interventions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provider Attribution in Medicare: Challenges and Solutions 医疗保险中的提供者归属:挑战和解决方案。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-28 DOI: 10.1111/1475-6773.70062
Caroline S. Carlin, Roger Feldman, Jeah Jung

Objective

To enhance National Provider Identifier (NPI) and specialty information available in Medicare Advantage (MA) encounter data and use the enhanced data to evaluate methods for retrospective attribution of the patient's usual clinician, comparing results across MA and Traditional Medicare (TM) populations.

Study Setting and Design

We fill in missing clinician identifiers and specialty codes in MA encounter data using Centers for Medicare and Medicaid Services (CMS) and publicly available provider datasets. We attributed patients to the usual clinician using 16 methodological options, comparing the performance of these attribution methods in MA and TM.

Data Sources and Analytic Sample

We used a 20% sample of MA encounter data and TM claims data for 2016–2022, incorporating information from CMS's Medicare Data on Provider Practice and Specialty, archived data from the National Plan and Provider Enumeration System, and specialty-taxonomy crosswalks derived from CMS publications.

Principal Findings

For MA, we identified individual NPIs for 83% of medical claims in 2016, improving to 89% in 2022. Among MA medical claims billed by physicians and advanced practice providers, 95% of NPIs were for individual clinicians by 2022. In total, we identified individual or organization NPIs and specialty codes for over 99% of medical encounters in both TM and MA in all years. Rates of patient attribution were stable over time, and most methods had similar performance in MA and TM. We recommend a hierarchical attribution method that resulted in the highest fraction attributed with good consistency of attributed clinician year over year. Published reference files and SAS code make these NPI identification and patient attribution methods accessible.

Conclusions

Our methods allow researchers to identify provider NPIs that can be matched to external clinician data, used to attribute patients to a usual source of care, or to fit clinician fixed effects in studies of MA and TM.

目的:增强医疗保险优势(MA)遭遇数据中的国家提供者标识符(NPI)和专业信息,并使用增强的数据来评估患者通常临床医生的回顾性归因方法,比较MA和传统医疗保险(TM)人群的结果。研究设置和设计:我们使用医疗保险和医疗补助服务中心(CMS)和公开可用的提供者数据集,在MA遭遇数据中填充缺失的临床医生标识符和专业代码。我们使用16种方法选择将患者归为常规临床医生,比较这些归因方法在MA和TM中的表现。数据来源和分析样本:我们使用了2016-2022年20%的MA就诊数据和TM索赔数据样本,结合了来自CMS的医疗保险数据关于提供者实践和专业的信息,来自国家计划和提供者枚举系统的存档数据,以及来自CMS出版物的专业分类交叉。主要发现:对于MA,我们在2016年确定了83%的医疗索赔的个人npi,到2022年将提高到89%。到2022年,在医生和高级执业提供者的MA医疗索赔中,95%的npi是针对临床医生个人的。总的来说,我们在所有年份中确定了超过99%的TM和MA医疗接触的个人或组织npi和专业代码。随着时间的推移,患者归因率保持稳定,大多数方法在MA和TM中的表现相似。我们推荐一种分层归因方法,其结果是归因比例最高,且归因临床医生的一致性较好。已发布的参考文件和SAS代码使这些NPI识别和患者归因方法易于访问。结论:我们的方法使研究人员能够确定提供者npi,这些npi可以与外部临床医生数据相匹配,用于将患者归因于通常的护理来源,或者适合临床医生在MA和TM研究中的固定效应。
{"title":"Provider Attribution in Medicare: Challenges and Solutions","authors":"Caroline S. Carlin,&nbsp;Roger Feldman,&nbsp;Jeah Jung","doi":"10.1111/1475-6773.70062","DOIUrl":"10.1111/1475-6773.70062","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To enhance National Provider Identifier (NPI) and specialty information available in Medicare Advantage (MA) encounter data and use the enhanced data to evaluate methods for retrospective attribution of the patient's usual clinician, comparing results across MA and Traditional Medicare (TM) populations.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>We fill in missing clinician identifiers and specialty codes in MA encounter data using Centers for Medicare and Medicaid Services (CMS) and publicly available provider datasets. We attributed patients to the usual clinician using 16 methodological options, comparing the performance of these attribution methods in MA and TM.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 <p>We used a 20% sample of MA encounter data and TM claims data for 2016–2022, incorporating information from CMS's Medicare Data on Provider Practice and Specialty, archived data from the National Plan and Provider Enumeration System, and specialty-taxonomy crosswalks derived from CMS publications.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>For MA, we identified individual NPIs for 83% of medical claims in 2016, improving to 89% in 2022. Among MA medical claims billed by physicians and advanced practice providers, 95% of NPIs were for individual clinicians by 2022. In total, we identified individual or organization NPIs and specialty codes for over 99% of medical encounters in both TM and MA in all years. Rates of patient attribution were stable over time, and most methods had similar performance in MA and TM. We recommend a hierarchical attribution method that resulted in the highest fraction attributed with good consistency of attributed clinician year over year. Published reference files and SAS code make these NPI identification and patient attribution methods accessible.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusions</h3>\u0000 <p>Our methods allow researchers to identify provider NPIs that can be matched to external clinician data, used to attribute patients to a usual source of care, or to fit clinician fixed effects in studies of MA and TM.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital Discharge Planning—An Investigation of Outcomes and Interventions 出院计划——结局和干预措施的调查。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-23 DOI: 10.1111/1475-6773.70060
Lena Imhof, Robin Heber, Kai Svane Blume, Jonas Schreyoegg, Vera Winter

Objective

To provide a comprehensive overview of the different types of hospital discharge planning (DP) interventions and outcomes examined in systematic reviews, and to assess the strength of evidence (SoE) for the associations between DP and these outcomes.

Study Setting and Design

Umbrella review (“review of systematic reviews”).

Data Sources

We searched five databases (PubMed, CINAHL, Web of Science, Cochrane, and Business Source Complete) from inception through February 2024 for systematic reviews examining associations between hospital DP and various outcomes. We conducted backward and forward citation searches to identify additional systematic reviews. Altogether, these searches yielded 1817 records, of which 34 met the inclusion criteria. We assessed the methodological quality of the included reviews using the AMSTAR 2 tool, summarized DP intervention types and the reviews' subgroup analyses narratively, and evaluated the SoE for 19 outcomes using a recently developed method.

Principal Findings

We identified 20 distinct DP intervention types which we grouped into six intervention categories. Patient education was the most frequently investigated type. We rated SoE as high for five outcomes, moderate for eight, and low for six. We found the strongest evidence for associations between hospital DP and reduced readmissions, fewer medication discrepancies, and greater patient satisfaction. Evidence for associations with quality of life, emergency department visits, mortality, and overall patient health, however, was weak or lacking. Our synthesis of the reviews' subgroup analyses indicated that the effects of hospital DP varied across patient populations and intervention types. Overall, the most effective interventions appeared to be high-intensity, bundled programs, incorporating medication-related interventions and follow-ups, particularly for reducing readmissions.

Conclusion

This umbrella review synthesizes evidence on associations between hospital DP and various outcomes. The findings support the development of tailored DP strategies and point to research gaps. Future studies should prioritize standardizing intervention definitions, outcome measures, and subgroup classifications, and investigate unexamined causal mechanisms.

目的:全面概述不同类型的出院计划(DP)干预措施和系统综述中检查的结果,并评估DP与这些结果之间关联的证据强度(SoE)。研究设置和设计:总括性评价(“系统评价的评价”)。数据来源:我们检索了五个数据库(PubMed, CINAHL, Web of Science, Cochrane和Business Source Complete),从成立到2024年2月,对医院DP与各种结果之间的关系进行了系统评价。我们进行了反向和正向引文检索,以确定额外的系统评价。这些检索共产生1817条记录,其中34条符合纳入标准。我们使用AMSTAR 2工具评估纳入的综述的方学质量,总结DP干预类型和综述的亚组分析,并使用最新开发的方法评估19个结果的SoE。主要发现:我们确定了20种不同的DP干预类型,并将其分为6个干预类别。患者教育是最常被调查的类型。我们在5个结果中将SoE评为高,8个结果为中等,6个结果为低。我们发现医院DP与减少再入院、减少用药差异和提高患者满意度之间存在最有力的关联。然而,与生活质量、急诊科就诊、死亡率和患者整体健康相关的证据很弱或缺乏。我们综合综述的亚组分析表明,医院DP的效果因患者群体和干预类型而异。总体而言,最有效的干预措施似乎是高强度的捆绑方案,结合药物相关干预和随访,特别是减少再入院。结论:本综述综合了医院DP与各种预后之间的关联证据。研究结果支持量身定制的DP策略的发展,并指出了研究差距。未来的研究应优先考虑标准化干预定义、结果测量和亚组分类,并调查未经检验的因果机制。
{"title":"Hospital Discharge Planning—An Investigation of Outcomes and Interventions","authors":"Lena Imhof,&nbsp;Robin Heber,&nbsp;Kai Svane Blume,&nbsp;Jonas Schreyoegg,&nbsp;Vera Winter","doi":"10.1111/1475-6773.70060","DOIUrl":"10.1111/1475-6773.70060","url":null,"abstract":"<div>\u0000 <section>\u0000 <h3> Objective</h3>\u0000 <p>To provide a comprehensive overview of the different types of hospital discharge planning (DP) interventions and outcomes examined in systematic reviews, and to assess the strength of evidence (SoE) for the associations between DP and these outcomes.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Study Setting and Design</h3>\u0000 <p>Umbrella review (“review of systematic reviews”).</p>\u0000 </section>\u0000 <section>\u0000 <h3> Data Sources</h3>\u0000 <p>We searched five databases (PubMed, CINAHL, Web of Science, Cochrane, and Business Source Complete) from inception through February 2024 for systematic reviews examining associations between hospital DP and various outcomes. We conducted backward and forward citation searches to identify additional systematic reviews. Altogether, these searches yielded 1817 records, of which 34 met the inclusion criteria. We assessed the methodological quality of the included reviews using the AMSTAR 2 tool, summarized DP intervention types and the reviews' subgroup analyses narratively, and evaluated the SoE for 19 outcomes using a recently developed method.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Principal Findings</h3>\u0000 <p>We identified 20 distinct DP intervention types which we grouped into six intervention categories. Patient education was the most frequently investigated type. We rated SoE as high for five outcomes, moderate for eight, and low for six. We found the strongest evidence for associations between hospital DP and reduced readmissions, fewer medication discrepancies, and greater patient satisfaction. Evidence for associations with quality of life, emergency department visits, mortality, and overall patient health, however, was weak or lacking. Our synthesis of the reviews' subgroup analyses indicated that the effects of hospital DP varied across patient populations and intervention types. Overall, the most effective interventions appeared to be high-intensity, bundled programs, incorporating medication-related interventions and follow-ups, particularly for reducing readmissions.</p>\u0000 </section>\u0000 <section>\u0000 <h3> Conclusion</h3>\u0000 <p>This umbrella review synthesizes evidence on associations between hospital DP and various outcomes. The findings support the development of tailored DP strategies and point to research gaps. Future studies should prioritize standardizing intervention definitions, outcome measures, and subgroup classifications, and investigate unexamined causal mechanisms.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of Maryland Primary Care Practices in Addressing Social Needs Through a Novel Value-Based Payment 马里兰州初级保健实践通过一种新颖的基于价值的支付方式来解决社会需求的经验。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-22 DOI: 10.1111/1475-6773.70058
Emily Gruber, Rachel Grisham, Hannah Arem, Claire M. Starling, Marjanna Smith, Felicia Dortch, Chad Perman

Objective

To understand perceived successes and challenges of the HEART payment, and opportunities for similar value-based payment mechanisms aiming to address health-related social needs.

Study Setting and Design

This study analyzes perceptions of primary care practices participating in the Maryland Primary Care Program (MDPCP) on the HEART payment, a value-based payment designed to support patients' social and medical needs. After a year of payment implementation, we gathered feedback through participant surveys and focus groups.

Data Sources and Analytic Sample

From February to March 2023, we administered a survey with 112 responses and held seven focus groups to collect primary data. For quantitative survey data, we summarized descriptive statistics and performed regression analyses to determine predictors of perceived value of the HEART payment. For qualitative focus group data, we coded and analyzed data to understand key themes on success factors and barriers to HEART payment implementation.

Principal Findings

The HEART payment was rated as high value for 61.3% of survey respondents. In bivariate regression analysis, the level of funds received and affiliation with a Care Transformation Organization (CTO) were associated with perceived value of the HEART payment; however, these associations were not significant in multivariate models. In focus groups, we found that the biggest perceived success of HEART was its unique ability to enable direct support for patients' health-related social needs, with practices using the payment to provide patients with resources such as transportation, medically necessary home remediations, and support for loneliness. Perceived challenges included the need for more precise patient eligibility targeting and administrative burdens.

Conclusions

The HEART payment is a promising new payment model that enables primary care practices to directly address patients' social needs. Future value-based payment models that incorporate social risk adjustments in provider payments may consider alternate methods to identify patients with a high burden of health-related social needs. This may include adjusting data points used to identify beneficiaries or allowing providers to directly identify patients.

目的:了解心脏支付的成功和挑战,以及旨在解决健康相关社会需求的类似基于价值的支付机制的机会。研究设置和设计:本研究分析了参与马里兰州初级保健计划(MDPCP)的初级保健实践对HEART支付的看法,HEART支付是一种基于价值的支付,旨在支持患者的社会和医疗需求。经过一年的付费执行,我们通过参与者调查和焦点小组收集反馈。数据来源和分析样本:我们于2023年2月至3月进行了一项有112份回复的调查,并举行了7个焦点小组来收集原始数据。对于定量调查数据,我们总结了描述性统计数据,并进行了回归分析,以确定心脏支付感知价值的预测因子。对于定性焦点小组数据,我们对数据进行编码和分析,以了解实施HEART支付的成功因素和障碍的关键主题。主要发现:61.3%的调查对象认为HEART支付价值高。在双变量回归分析中,收到的资金水平和与护理转型组织(CTO)的隶属关系与心脏支付的感知价值相关;然而,这些关联在多变量模型中并不显著。在焦点小组中,我们发现,HEART最大的成功之处在于其独特的能力,即能够直接支持患者与健康相关的社会需求,通过使用付款为患者提供交通、医疗必要的家庭修复和孤独支持等资源。面临的挑战包括需要更精确的患者资格定位和行政负担。结论:心脏支付是一种有前途的新型支付模式,使初级保健实践能够直接解决患者的社会需求。未来基于价值的支付模式将社会风险调整纳入提供者支付中,可以考虑采用替代方法来识别与健康相关的社会需求负担高的患者。这可能包括调整用于识别受益人的数据点或允许提供者直接识别患者。
{"title":"Experiences of Maryland Primary Care Practices in Addressing Social Needs Through a Novel Value-Based Payment","authors":"Emily Gruber,&nbsp;Rachel Grisham,&nbsp;Hannah Arem,&nbsp;Claire M. Starling,&nbsp;Marjanna Smith,&nbsp;Felicia Dortch,&nbsp;Chad Perman","doi":"10.1111/1475-6773.70058","DOIUrl":"10.1111/1475-6773.70058","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To understand perceived successes and challenges of the HEART payment, and opportunities for similar value-based payment mechanisms aiming to address health-related social needs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Setting and Design</h3>\u0000 \u0000 <p>This study analyzes perceptions of primary care practices participating in the Maryland Primary Care Program (MDPCP) on the HEART payment, a value-based payment designed to support patients' social and medical needs. After a year of payment implementation, we gathered feedback through participant surveys and focus groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 \u0000 <p>From February to March 2023, we administered a survey with 112 responses and held seven focus groups to collect primary data. For quantitative survey data, we summarized descriptive statistics and performed regression analyses to determine predictors of perceived value of the HEART payment. For qualitative focus group data, we coded and analyzed data to understand key themes on success factors and barriers to HEART payment implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>The HEART payment was rated as high value for 61.3% of survey respondents. In bivariate regression analysis, the level of funds received and affiliation with a Care Transformation Organization (CTO) were associated with perceived value of the HEART payment; however, these associations were not significant in multivariate models. In focus groups, we found that the biggest perceived success of HEART was its unique ability to enable direct support for patients' health-related social needs, with practices using the payment to provide patients with resources such as transportation, medically necessary home remediations, and support for loneliness. Perceived challenges included the need for more precise patient eligibility targeting and administrative burdens.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The HEART payment is a promising new payment model that enables primary care practices to directly address patients' social needs. Future value-based payment models that incorporate social risk adjustments in provider payments may consider alternate methods to identify patients with a high burden of health-related social needs. This may include adjusting data points used to identify beneficiaries or allowing providers to directly identify patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Services Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1